Joint Formulary & PAD

Azathioprine - Uveitis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Amber
Formulations :
  • Oral suspension
  • Tablets
Associated Icons :
Off Label
SPC
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Azathioprine
Indication :
Uveitis
Group Name :
Keywords :
RMOC, national shared care
Brand Names Include :
Imuran, Jayempi
Important Information :

Principles for shared care found here: https://surrey.res.services/PAD/Profile/NonClinicalProfile/9136

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Committee Recommendations (1)

The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) has agreed the National Shared Care Protocol for azathioprine and mercaptopurine for patients in adult services (non- transplant indications)